Michael Bailey Associates Pharmaceutical division expands to Asia Pacific!
With established and dedicated Pharmaceutical and Life Sciences operations in Switzerland, Germany and the UK, we are expanding the division to the Asia Pacific region based in our Singapore office.
The development of our Pharmaceutical and Life Sciences offering is a result of the great success that we've had in the European market, particularly with our clients. The team has been working with some of the most prestigious Pharmaceutical companies in Europe which led to clients now asking us to work with them on their global projects.
“Singapore is the ultimate hub for the Pharmaceutical industry in Asia. The industry is becoming more and more attracted to the region’s commitment to research and development, innovation and trusted regulatory environment.
With strict, thorough laws in place and the local governments offering up to 50% in foreign investments, UK and US Pharmaceutical organisations are looking to Singapore to gain market share. As we are already established in the industry with an office in the region, it was a natural progression to grow our Pharmaceutical division to Singapore”, Mike Garlick, CEO.
Initial Pharmaceutical and Life Science projects will come from developing existing relationships with key clients in the business. We will look towards working on projects such as research and development, equipment manufacturing and medical devices used in high-end surgery.
“It’s our aim to work strategically with our clients on a local and global basis in order to hire top-tier local and foreign talent”, Shagar, Country Manager.
